Nicholas Short, MD
The University of Texas MD Anderson Cancer Center
Latest Content
CML and Ph+ ALL
11/05/2026
Ep. 2: OPTIC Study Informs Ponatinib Dosing and Treatment Sequencing in CML
CML and Ph+ ALL
10/29/2026
Ep. 1: Treatment Selection and Sequencing Strategies for Chronic-Phase CML
FLT3-Mutated AML
07/28/2026
Ep. 4: FLT3-Mutated AML: Targeted Therapy From Diagnosis Through Long-Term Management
FLT3-Mutated AML
07/27/2026
Ep. 3: FLT3-Mutated AML: Maintenance Therapy, Triplet Regimens, and Relapse Management
FLT3-Mutated AML
07/24/2026
Ep. 2: FLT3 Inhibitors Continue to Expand Treatment Opportunities in Acute Myeloid Leukemia
FLT3-Mutated AML
07/23/2026